Featured Research

from universities, journals, and other organizations

Champagne is good for your heart, study suggests -- but only in moderation

Date:
December 31, 2009
Source:
University of Reading
Summary:
Research from the UK suggests that two glasses of champagne a day may be good for your heart and circulation. The researchers have found that drinking champagne wine daily in moderate amounts causes improvements in the way blood vessels function.

Champagne toast.
Credit: iStockphoto/Carolyn De Anda

Research from the University of Reading suggests that two glasses of champagne a day may be good for your heart and circulation. The researchers have found that drinking champagne wine daily in moderate amounts causes improvements in the way blood vessels function.

Champagne does this by increasing the availability of nitric oxide, a vascular active molecule which controls blood pressure. It is able to induce these effects because it contains polyphenols, plant chemicals from the red grapes and white grapes used in champagne production.

When you drink champagne, these polyphenols get absorbed into the circulation where they are able to act on the vascular system. Specifically, they appear to slow down the natural removal of nitric oxide from our blood, meaning that it will have a longer time to act on blood vessels and so improve the flow of blood around the body.

High nitric oxide levels in the blood, as a result of drinking champagne, can have beneficial effects, because as well as increasing blood flow, it may help to decrease both blood pressure and the likelihood of blood clots forming. This could therefore reduce the risks of suffering from cardiovascular disease and stroke, but more research needs to be done to determine the long term effects of daily champagne consumption.

Dr Jeremy Spencer, from the Department of Food and Nutritional Sciences said: "Our research has shown that drinking around two glasses of champagne can have beneficial effects on the way blood vessels function, in a similar way to that observed with red wine. We always encourage a responsible approach to alcohol consumption, but the fact that drinking champagne has the potential to reduce the risks of suffering from cardiovascular diseases such as heart disease and stroke, is very exciting news."


Story Source:

The above story is based on materials provided by University of Reading. Note: Materials may be edited for content and length.


Journal Reference:

  1. David Vauzour, Emily J. Houseman, Trevor W. George, Giulia Corona1, Roselyne Garnotel, Kim G. Jackson, Christelle Sellier, Philippe Gillery, Orla B. Kennedy, Julie A. Lovegrove and Jeremy P. E. Spencer. Moderate Champagne consumption promotes an acute improvement in acute endothelial-independent vascular function in healthy human volunteers. British Journal of Nutrition, 2009; DOI: 10.1017/S0007114509992959

Cite This Page:

University of Reading. "Champagne is good for your heart, study suggests -- but only in moderation." ScienceDaily. ScienceDaily, 31 December 2009. <www.sciencedaily.com/releases/2009/12/091215163537.htm>.
University of Reading. (2009, December 31). Champagne is good for your heart, study suggests -- but only in moderation. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/12/091215163537.htm
University of Reading. "Champagne is good for your heart, study suggests -- but only in moderation." ScienceDaily. www.sciencedaily.com/releases/2009/12/091215163537.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins